| Melissa Camelia Martyn, NP | |
|
20 S Broadway, Mha 11th Floor, Yonkers, NY 10701-3713 | |
| (718) 964-6161 | |
| Not Available |
| Full Name | Melissa Camelia Martyn |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 20 S Broadway, Yonkers, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003290362 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | F402498 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Modern Psychiatric Nurse Practitioner Pc | 0840570297 | 12 |
| New York Gracie Square Hospital Inc | 5698666758 | 46 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter ended September 30, 2009.
Alexion Pharmaceuticals, Inc. today announced that it has completed enrolling patients in all four previously announced prospective, open-label clinical studies investigating Soliris® (eculizumab) as a potential treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) being conducted in North America and multiple European countries.
A collaborative study led by scientists from the Mechanobiology Institute at the National University of Singapore has revealed the mechanical forces that drive epithelial wound healing in the absence of cell supporting environment. This research was published in Nature Communications in January 2015.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.
› Verified 2 days ago
| Entity Name | New York Gracie Square Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215911946 PECOS PAC ID: 5698666758 Enrollment ID: O20040320000381 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter ended September 30, 2009.
Alexion Pharmaceuticals, Inc. today announced that it has completed enrolling patients in all four previously announced prospective, open-label clinical studies investigating Soliris® (eculizumab) as a potential treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) being conducted in North America and multiple European countries.
A collaborative study led by scientists from the Mechanobiology Institute at the National University of Singapore has revealed the mechanical forces that drive epithelial wound healing in the absence of cell supporting environment. This research was published in Nature Communications in January 2015.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.
› Verified 2 days ago
| Entity Name | Modern Psychiatric Nurse Practitioner Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518415983 PECOS PAC ID: 0840570297 Enrollment ID: O20161201000875 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter ended September 30, 2009.
Alexion Pharmaceuticals, Inc. today announced that it has completed enrolling patients in all four previously announced prospective, open-label clinical studies investigating Soliris® (eculizumab) as a potential treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) being conducted in North America and multiple European countries.
A collaborative study led by scientists from the Mechanobiology Institute at the National University of Singapore has revealed the mechanical forces that drive epithelial wound healing in the absence of cell supporting environment. This research was published in Nature Communications in January 2015.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.
› Verified 2 days ago
| Entity Name | Psychiatric Nurse Practitioner P.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518595727 PECOS PAC ID: 6901221795 Enrollment ID: O20200811001572 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter ended September 30, 2009.
Alexion Pharmaceuticals, Inc. today announced that it has completed enrolling patients in all four previously announced prospective, open-label clinical studies investigating Soliris® (eculizumab) as a potential treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) being conducted in North America and multiple European countries.
A collaborative study led by scientists from the Mechanobiology Institute at the National University of Singapore has revealed the mechanical forces that drive epithelial wound healing in the absence of cell supporting environment. This research was published in Nature Communications in January 2015.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Camelia Martyn, NP 20 S Broadway, Mha 11th Floor, Yonkers, NY 10701-3713 Ph: () - | Melissa Camelia Martyn, NP 20 S Broadway, Mha 11th Floor, Yonkers, NY 10701-3713 Ph: (718) 964-6161 |
News Archive
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited financial results for the quarter ended September 30, 2009.
Alexion Pharmaceuticals, Inc. today announced that it has completed enrolling patients in all four previously announced prospective, open-label clinical studies investigating Soliris® (eculizumab) as a potential treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) being conducted in North America and multiple European countries.
A collaborative study led by scientists from the Mechanobiology Institute at the National University of Singapore has revealed the mechanical forces that drive epithelial wound healing in the absence of cell supporting environment. This research was published in Nature Communications in January 2015.
In this post in the State Department's "Dipnote" blog, David Robinson, acting assistant secretary of state for the Bureau of Population, Refugees and Migration, reports on gender-based violence (GBV) among refugee populations, writing, "Displaced women and children are especially vulnerable to gender-based violence. ... Without legal status or the protection of any government, stateless women and girls are also vulnerable to exploitation and abuse, including trafficking in persons.
Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.
› Verified 2 days ago
Ms. Mary Ellen Ryan, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 919 Bdway, Yonkers, NY 10701 Phone: 914-968-1900 | |
Mrs. Cigi Mathew, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 970 N Broadway, Suite 305 B, Yonkers, NY 10701 Phone: 914-375-6400 | |
Christine Sosenko-porytko, F.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2 Park Ave, Hudson River Healthcare, Inc., Yonkers, NY 10703 Phone: 914-964-7862 Fax: 914-964-7307 | |
Mr. Norris Ogard, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Larkin Ctr, Yonkers, NY 10701 Phone: 914-376-8226 | |
Ms. Folasayo Ore-ofe Adaramola, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 465 Scarsdale Rd, Yonkers, NY 10707 Phone: 917-755-5512 | |
Princess Okunola, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1990 Central Park Ave, Yonkers, NY 10710 Phone: 914-793-5588 |